TEVA PHARMACEUTICAL INDUSTRIES LTD Bonus & Incentive Agreements
19 Contracts & Agreements
- Teva Pharmaceutical Industries Limited Israeli Subplan of Tevas 2020 Long-Term Equity-Based Incentive Plan (Filed With SEC on November 5, 2020)
- Form Award Agreement under Tevas 2020 Long-Term Equity-Based Incentive Plan (Filed With SEC on November 5, 2020)
- Form Award Agreement (RSUs and PSUs) under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan (Filed With SEC on February 21, 2020)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2016 grants and 2017 grants made to... (Filed With SEC on February 21, 2020)
- Michael McClellan Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to September 18, 2017 grant (Filed With SEC on February 12, 2018)
- 2018 Form Bonus Letter Agreement (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2018 grants made to Kre Schultz, Michael... (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2010 Long-Term Equity-Based Incentive Plan applicable to selected 2015 grants made to Mark Sabag, Carlo de... (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2016 grants made to Mark Sabag, Carlo de... (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2017 grants made to Mark Sabag, Michael... (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2015 grants made to Michael McClellan (Filed With SEC on February 12, 2018)
- Hafrun Fridriksdottir Substitute Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to August 2, 2016... (Filed With SEC on February 12, 2018)
- Hafrun Fridriksdottir Substitute Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to August 2, 2016 stock... (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2016 grants made to Michael McClellan and... (Filed With SEC on February 12, 2018)
- Carlo de Notaristefani Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to May 18, 2017 grant (Filed With SEC on February 12, 2018)
- Kre Schultz Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to November 3, 2017 grant (Filed With SEC on February 12, 2018)
- Hafrun Fridriksdottir Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2016 grants (Filed With SEC on February 12, 2018)
- Form Director Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2015, 2016 and 2017 grants (Filed With SEC on February 12, 2018)
- 2017 Form Bonus Letter Agreement, applicable to Rob Koremans, Dr. Michael Hayden, Hafrun Fridriksdottir, Carlo de Notaristefani, Eyal Desheh and Mark Sabag (Filed With SEC on February 12, 2018)
